Sintx Technologies, Inc. (NASDAQ:SINT – Get Free Report) saw a significant decline in short interest in June. As of June 15th, there was short interest totaling 124,886 shares, a decline of 36.2% from the May 31st total of 195,626 shares. Currently, 3.0% of the company’s stock are short sold. Based on an average daily volume of 100,500 shares, the short-interest ratio is presently 1.2 days.
Analyst Ratings Changes
SINT has been the subject of several recent research reports. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price objective on shares of Sintx Technologies in a research report on Wednesday, May 20th. Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a research report on Tuesday, April 21st. Ascendiant Capital Markets cut their target price on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Finally, Maxim Group reaffirmed a “buy” rating and set a $6.00 price target on shares of Sintx Technologies in a research report on Thursday, June 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $9.33.
View Our Latest Research Report on Sintx Technologies
Institutional Inflows and Outflows
Sintx Technologies Stock Performance
Shares of SINT stock opened at $1.90 on Friday. The firm’s fifty day moving average price is $2.18 and its two-hundred day moving average price is $2.78. Sintx Technologies has a 1 year low of $1.80 and a 1 year high of $6.78. The firm has a market capitalization of $8.21 million, a P/E ratio of -0.37 and a beta of 0.63.
Sintx Technologies (NASDAQ:SINT – Get Free Report) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). The business had revenue of $0.38 million for the quarter, compared to analyst estimates of $0.30 million. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%. As a group, equities research analysts forecast that Sintx Technologies will post -2.22 EPS for the current fiscal year.
About Sintx Technologies
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Featured Articles
- Five stocks we like better than Sintx Technologies
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
